new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab)

You'll hear about a new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab).

It's the first new lupus drug in 50 years...and the first biologic.

This is amazing when you consider that lupus affects up to 1.5 million people...mainly women.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote